Marlies Götz

1.0k total citations
32 papers, 682 citations indexed

About

Marlies Götz is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Marlies Götz has authored 32 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 15 papers in Immunology and 13 papers in Oncology. Recurrent topics in Marlies Götz's work include Acute Myeloid Leukemia Research (11 papers), CAR-T cell therapy research (9 papers) and Immune Cell Function and Interaction (8 papers). Marlies Götz is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), CAR-T cell therapy research (9 papers) and Immune Cell Function and Interaction (8 papers). Marlies Götz collaborates with scholars based in Germany, China and Switzerland. Marlies Götz's co-authors include Jochen Greiner, Hartmut Döhner, Michael Schmitt, Donald Bunjes, Anita Schmitt, Philippe Guillaume, Susanne Hofmann, Markus Rojewski, Yingzhe Yu and Fei Fei and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Marlies Götz

32 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marlies Götz Germany 14 358 326 276 224 105 32 682
Rhoda Eniafe United States 12 339 0.9× 268 0.8× 209 0.8× 132 0.6× 89 0.8× 18 529
Bijan Moshaver Netherlands 11 210 0.6× 437 1.3× 225 0.8× 253 1.1× 99 0.9× 20 743
Kyrie Felio United States 7 543 1.5× 319 1.0× 234 0.8× 107 0.5× 117 1.1× 7 766
Antoinette Chillemi United States 11 429 1.2× 358 1.1× 206 0.7× 135 0.6× 76 0.7× 12 718
Chiara Gentilini Germany 14 605 1.7× 252 0.8× 396 1.4× 177 0.8× 99 0.9× 24 932
S. M. Luger United States 8 274 0.8× 492 1.5× 372 1.3× 407 1.8× 141 1.3× 14 949
Cecilia Muñoz‐Calleja Spain 15 307 0.9× 111 0.3× 286 1.0× 199 0.9× 111 1.1× 41 696
Alexandra Croockewit Netherlands 12 367 1.0× 396 1.2× 361 1.3× 366 1.6× 93 0.9× 20 801
Harumi Kakuda Japan 12 586 1.6× 398 1.2× 474 1.7× 211 0.9× 72 0.7× 28 947
Lisa P. Chu United States 6 348 1.0× 260 0.8× 103 0.4× 243 1.1× 87 0.8× 8 786

Countries citing papers authored by Marlies Götz

Since Specialization
Citations

This map shows the geographic impact of Marlies Götz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlies Götz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlies Götz more than expected).

Fields of papers citing papers by Marlies Götz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlies Götz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlies Götz. The network helps show where Marlies Götz may publish in the future.

Co-authorship network of co-authors of Marlies Götz

This figure shows the co-authorship network connecting the top 25 collaborators of Marlies Götz. A scholar is included among the top collaborators of Marlies Götz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlies Götz. Marlies Götz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guinn, Barbara‐ann, Patrick J. Schuler, Hubert Schrezenmeier, et al.. (2023). A Combination of the Immunotherapeutic Drug Anti-Programmed Death 1 with Lenalidomide Enhances Specific T Cell Immune Responses against Acute Myeloid Leukemia Cells. International Journal of Molecular Sciences. 24(11). 9285–9285. 4 indexed citations
2.
Greiner, Jochen, Marlies Götz, & Verena Wais. (2022). Increasing Role of Targeted Immunotherapies in the Treatment of AML. International Journal of Molecular Sciences. 23(6). 3304–3304. 14 indexed citations
3.
Greiner, Jochen, Vanessa Schneider, Hubert Schrezenmeier, Susanne Hofmann, & Marlies Götz. (2021). Enhanced Stimulation of Antigen-Specific Immune Responses Against NPM1-Mutated AML. Blood. 138(Supplement 1). 1292–1292. 1 indexed citations
4.
Greiner, Jochen, Marlies Götz, Constanze Wendt, et al.. (2020). Characteristics and mechanisms to control a COVID‐19 outbreak on a leukemia and stem cell transplantation unit. Cancer Medicine. 10(1). 237–246. 4 indexed citations
5.
Greiner, Jochen, Marlies Götz, Susanne Hofmann, et al.. (2020). Specific T-cell immune responses against colony-forming cells including leukemic progenitor cells of AML patients were increased by immune checkpoint inhibition. Cancer Immunology Immunotherapy. 69(4). 629–640. 12 indexed citations
6.
Götz, Marlies, Jochen Greiner, Simon Laban, et al.. (2020). Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and Immunotherapy. International Journal of Molecular Sciences. 21(15). 5181–5181. 22 indexed citations
7.
Greiner, Jochen, Vanessa Schneider, Hubert Schrezenmeier, et al.. (2020). Frequency and Stimulation of NPM1-Specific Immune Responses By Anti-PD1 Antibodies in NPM1-Mutated AML. Blood. 136(Supplement 1). 15–15. 2 indexed citations
8.
Greiner, Jochen, Marlies Götz, Donald Bunjes, Susanne Hofmann, & Verena Wais. (2019). Immunological and Clinical Impact of Manipulated and Unmanipulated DLI after Allogeneic Stem Cell Transplantation of AML Patients. Journal of Clinical Medicine. 9(1). 39–39. 20 indexed citations
9.
Hofmann, Susanne, Michael Schmitt, Marlies Götz, et al.. (2018). Donor lymphocyte infusion leads to diversity of specific T cell responses and reduces regulatory T cell frequency in clinical responders. International Journal of Cancer. 144(5). 1135–1146. 10 indexed citations
10.
Greiner, Jochen, Marlies Götz, Vanessa Schneider, et al.. (2016). Specific Immune Responses for Leukemia-Associated Antigens Against Myeloid Leukemic Cells Are Increased By Immune Checkpoint Inhibition. Blood. 128(22). 4054–4054. 1 indexed citations
11.
Schneider, Vanessa, Lu Zhang, Markus Rojewski, et al.. (2015). Leukemic progenitor cells are susceptible to targeting by stimulated cytotoxic T cells against immunogenic leukemia‐associated antigens. International Journal of Cancer. 137(9). 2083–2092. 16 indexed citations
12.
Bullinger, Lars, Richard F. Schlenk, Marlies Götz, et al.. (2013). PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17). Clinical Cancer Research. 19(9). 2562–2571. 31 indexed citations
13.
Götz, Marlies, et al.. (2013). Frequent T cell responses against immunogenic targets in lung cancer patients for targeted immunotherapy. Oncology Reports. 31(1). 384–390. 17 indexed citations
14.
Schneider, Vanessa, et al.. (2012). Specific immune responses against epitopes derived from Aurora kinase A and B in acute myeloid leukemia. Leukemia & lymphoma. 54(7). 1500–1504. 3 indexed citations
15.
Fei, Fei, Yingzhe Yu, Anita Schmitt, et al.. (2010). Effects of nilotinib on regulatory T cells: the dose matters. Molecular Cancer. 9(1). 22–22. 22 indexed citations
16.
Fei, Fei, Yingzhe Yu, Anita Schmitt, et al.. (2009). The Inhibitory Effect of Cyclosporine A and Prednisolone on Both Cytotoxic CD8+ T Cells and CD4+CD25+ Regulatory T Cells. Current Signal Transduction Therapy. 4(3). 222–233. 1 indexed citations
17.
Yao, Junxia, Markus Wiesneth, Georg Härter, et al.. (2008). Multimer Staining of Cytomegalovirus Phosphoprotein 65–Specific T Cells for Diagnosis and Therapeutic Purposes: A Comparative Study. Clinical Infectious Diseases. 46(10). e96–e105. 39 indexed citations
18.
Fei, Fei, Yingzhe Yu, Anita Schmitt, et al.. (2008). Dasatinib exerts an immunosuppressive effect on CD8+ T cells specific for viral and leukemia antigens. Experimental Hematology. 36(10). 1297–1308. 60 indexed citations
19.
Fei, Fei, Yingzhe Yu, Anita Schmitt, et al.. (2008). Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells. British Journal of Haematology. 144(2). 195–205. 54 indexed citations
20.
Brunner, Peter, et al.. (1992). [Adherence of pacemaker electrodes to the endomyocardium--a postmortem study].. PubMed. 44(1). 3–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rhoda Eniafe Breakdown of academic impact, for papers by Bijan Moshaver Breakdown of academic impact, for papers by Kyrie Felio Breakdown of academic impact, for papers by Antoinette Chillemi Breakdown of academic impact, for papers by Chiara Gentilini Breakdown of academic impact, for papers by S. M. Luger Breakdown of academic impact, for papers by Cecilia Muñoz‐Calleja Breakdown of academic impact, for papers by Alexandra Croockewit Breakdown of academic impact, for papers by Harumi Kakuda Breakdown of academic impact, for papers by Lisa P. Chu
Rankless by CCL
2026